Drawing for ONC-ADEPT

USPTO serial 79345489

ONC-ADEPT

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
SINGH, DEEP K
Law office
TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONC-ADEPT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations and reagents for scientific or research use; Chemical reagents for non-medical purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry, science and medical research; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus; diagnostic biomarkers, namely, nucleic acids, proteins and other biochemical ligands for scientific or research use; diagnostic kits comprised of diagnostic reagents and assay components for scientific research, clinical and medical laboratory useACTIVE—
005Diagnostic medical reagents and assay components for testing of body fluids including blood and plasma, and cells; diagnostic kits comprised of diagnostic reagents and assay components for clinical, medical and medical laboratory use; all the foregoing not including any such goods that are prescription only pharmaceuticals, but including such non-pharmaceutical goods that are for companion diagnosticsACTIVE—
009Apparatus, equipment and instruments for cytology, histology and for use in detecting cancerous conditions not for medical use, but all for laboratory use, diagnostic or general research use in the fields of cytology and histology; laboratory apparatus in the nature of cassettes for harvesting rare cells for use in laboratory, diagnostic or general research use; cell analyser providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes therefor; apparatus for use in testing and analysing blood and blood cells not for medical use, and all for laboratory use, diagnostic or general research use; parts and fittings for the aforesaid goods, namely medical laboratory research instruments for use in the detection of cancerACTIVE—
010Medical apparatus, equipment and instruments for laboratory analysis and clinical diagnosis of human diseases; medical testing apparatus, equipment and instruments for testing body fluids, blood and plasma, cancer cells, and foetal cells; medical testing kits for use in detecting cancerous conditions; parts and fittings for the aforesaid goods, namely, diagnostic apparatus, equipment and instruments for cytology, histology and for use in detecting cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 23, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 7, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 29, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 4, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 3, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 5, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 6, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 13, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 27, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 27, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 1, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 1, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Aug 1, 2023CNSLSUSPENSION LETTER WRITTEN—
Jul 3, 2023DOCKASSIGNED TO EXAMINER—
Jun 9, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 8, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 8, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 26, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 26, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 26, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 26, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 26, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 26, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 10, 2023RFNTREFUSAL PROCESSED BY IB—
Dec 19, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 19, 2022RFRRREFUSAL PROCESSED BY MPU—
Oct 6, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 5, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2022DOCKASSIGNED TO EXAMINER—
Jul 26, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 21, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance